A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects
Open Access
- 5 November 2008
- journal article
- case report
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 17 (5), 565-572
- https://doi.org/10.1038/ejhg.2008.204
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dimorphic effects of Notch signaling in bone homeostasisNature Medicine, 2008
- Torg–Winchester syndrome: lack of efficacy of pamidronate therapyClinical Dysmorphology, 2007
- Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growthHuman Molecular Genetics, 2007
- Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteinsJournal of Leukocyte Biology, 2006
- The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosisJournal of Medical Genetics, 2006
- Mutations in NOTCH1 cause aortic valve diseaseNature, 2005
- Cardiac morphogenesis: Matrix metalloproteinase coordination of cellular mechanisms underlying heart tube formation and directionality of loopingDevelopmental Dynamics, 2005
- GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5Nature, 2003
- Elevated glucose inhibits VEGF-A–mediated endocardial cushion formationThe Journal of cell biology, 2003
- Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism RevealedScience, 1999